Researchers in China developed a 'one-pot' Cas12i3/Cas13d-based assay, designated OBServe.v2, to discriminate between ASFV ...
News-Medical.Net on MSN
Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR
Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback